CODX vs CTRA · rev $3.9M vs P/E 15, rev $5.46B
Co-Diagnostics, Inc. Common Stock (CODX) versus Coterra Energy Inc (CTRA) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Coterra Energy Inc (CTRA) is a oil & gas e&p company listed on US.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported CTRA revenue for 2024-12-31 was $5.46B. Net income was $1.12B. Revenue was down 7.7% from 2023-12-31 to 2024-12-31. CTRA currently screens at market cap $20.46B and trailing P/E 15.2.
CODX currently screens at market cap $31.4M. CTRA currently screens at market cap $20.46B and trailing P/E 15.2.
Not investment advice. Open the CODX and CTRA stock pages for the full models.
Not investment advice.